Impact of the COVID-19 Pandemic on Behavioral Symptoms in Dementia
Overview
The COVID-19 pandemic has led to an increase in behavioral and psychological symptoms of dementia (BPSD) among nursing home residents, particularly depressive symptoms. This study highlights the need for enhanced mental health support and screening during public health emergencies.
Background
The COVID-19 pandemic has significantly affected nursing home residents, leading to increased social isolation and changes in care practices. Behavioral and psychological symptoms of dementia are prevalent in this population and can worsen cognitive impairment and caregiver burden. Understanding the impact of the pandemic on BPSD is crucial for improving care strategies in nursing homes.
Data Highlights
Change to a more accessible format, such as a list or bullet points, instead of a table.
Key Findings
The prevalence of two or more BPSDs increased from 19.0% in 2019 to 20.2% in 2020.
Depressive symptoms increased by 63%, from 17.4% in 2019 to 28.3% in 2020.
Psychosis-related symptoms showed minimal change, remaining at 5.6% to 5.7%.
Agitation-related symptoms decreased slightly from 30.0% to 29.6%.
Antipsychotic and sedative use decreased, while antidepressant and antianxiety use remained steady.
Increased reliance on psychotropic medications may have resulted from changes in care practices during the pandemic.
Clinical Implications
Healthcare providers should prioritize depression screening and mental health support for nursing home residents, especially during public health emergencies. Non-pharmacological interventions should remain the first-line approach for managing BPSD, necessitating adequate staffing and resources.
Conclusion
The findings underscore the significant impact of the COVID-19 pandemic on behavioral symptoms in dementia, highlighting the need for improved mental health care strategies in nursing homes.
